Cite

HARVARD Citation

    Buffa, P. et al. (2014). BCR‐ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein. FASEB journal. 28 (3), pp. 1221-1236. [Online]. 
  
Back to record